|
|
|
|
|
Name |
Applicable Area |
Patent Status |
| Novel PEG Derivatives |
Novel methoxy PEG propion-aldehydes, novel methoxy PEG butylaldehydes, etc. |
To allow novel method of N-terminal pegylation of therapeutic proteins |
Korean and US patents |
| Novel Y-PEG derivatives of M.W.40K |
To allow single pegylation of 40K PEG
|
Korean and US Patents
|
|
Novel 6-arm PEG Derivatives
|
Drug delivery and medical devices
|
Korean and US Patents
|
|
|
|
|
| Drug Candidates |
Cysferon-alpha (mutein interferon-alpha with site-specific pegylation) |
Hepatitis C, Anti-viral |
Korean and US patents |
|
PEG-Interferon alpha |
Proprietary or generic formulation |
Korean and US patents |
|
PEG-GCSF
|
Proprietary or generic formulation
|
Korean and US patents |
|
PEG-EPO
|
Proprietary of generic formulation
|
Korean and US patents |
|
Other PEG-proteins
|
Proprietary of generic formulation
|
Korean and US patents |
|
|
|
|
| Drug Development Technologies |
Site-specific mutagenesis and pegylation of proteins |
Development of novel drug candidates |
Korean and US patents |
|
Cell engineering technology |
Prevention of graft rejection of transplant cells |
Korean and US patents |
|
Novel pegylation Technologies |
Development of novel PEG-biopharmaceuticals |
Korean and US patents |
|
|
|
|
